Gkv Capital Management Co., Inc. Abbott Laboratories Transaction History
Gkv Capital Management Co., Inc.
- $245 Billion
- Q4 2024
A detailed history of Gkv Capital Management Co., Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 200 shares of ABT stock, worth $26,122. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200Holding current value
$26,122% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,336Shares Held
1.36BCall Options Held
10MPut Options Held
9.48M-
Vanguard Group Inc Valley Forge, PA169MShares$22 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.1 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.88 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.07 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...